{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:29:58Z","timestamp":1789781398266,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ymgme.2010.11.003","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T09:43:29Z","timestamp":1289468609000},"page":"122-125","source":"Crossref","is-referenced-by-count":52,"title":["Increase of CSF tyrosine and impaired serotonin turnover in tyrosinemia type I"],"prefix":"10.1016","volume":"102","author":[{"given":"Eva","family":"Thimm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diran","family":"Herebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Klee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"Mayatepek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Spiekerkoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.11.003_bb0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"1777","article-title":"Hypertyrosinemia","author":"Mitchell","year":"2001"},{"key":"10.1016\/j.ymgme.2010.11.003_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00711742","article-title":"Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation","volume":"18","author":"van Spronsen","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"3","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2010.11.003_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1089-3261(05)70142-2","article-title":"Nontransplant treatment of tyrosinemia","volume":"4","author":"Holme","year":"2000","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00244-008-9145-2","article-title":"Toxicity assessment of the herbicides sulcotrione and mesotrione toward two reference environmental microorganisms: Tetrahymena pyriformis and Vibrio fischeri","volume":"55","author":"Bonnet","year":"2008","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1005410820201","article-title":"Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione)","volume":"21","author":"Holme","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0002-9394(01)01160-6","article-title":"Tyrosinemia type II: nine cases of ocular signs and symptoms","volume":"132","author":"Macsai","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1023\/A:1013936107064","article-title":"Outcome of tyrosinaemia type III","volume":"24","author":"Ellaway","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1016558510123","article-title":"Pregnancy and tyrosinaemia type II","volume":"25","author":"Cerone","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijdevneu.2008.05.007","article-title":"Tyrosine promotes oxidative stress in cerebral cortex of young rats","volume":"26","author":"Sgaravatti","year":"2008","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.rct.0000163179.10595.c4","article-title":"Tyrosinemia: computed tomography, magnetic resonance imaging, diffusion magnetic resonance imaging, and proton spectroscopy findings in the brain","volume":"29","author":"Sener","year":"2005","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0065","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/02841850510021517","article-title":"Brain magnetic resonance imaging in tyrosinemia","volume":"46","author":"Sener","year":"2005","journal-title":"Acta Radiol."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1005389110739","article-title":"Adult psychosocial outcome in early-treated phenylketonuria","volume":"20","author":"Ris","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0075","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/PL00014388","article-title":"Development of intelligence in early treated phenylketonuria","volume":"159","author":"Burgard","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0080","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jchromb.2009.03.014","article-title":"Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1, 3-cyclohexanedione) in plasma of tyrosinemia type 1 patients","volume":"877","author":"Herebian","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ymgme.2010.11.003_bb0085","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/clinchem\/44.9.1897","article-title":"Biochemical hallmarks of tyrosine hydroxylase deficiency","volume":"44","author":"Br\u00e4utigam","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0090","doi-asserted-by":"crossref","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","article-title":"Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain","volume":"137","author":"Fernstrom","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0095","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1007\/BF01799701","article-title":"Dietary problems of phenylketonuria: effect on CNS transmitterrs and their possible role in behaviour and neuropsychological function","volume":"9","author":"G\u00fcttler","year":"1986","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-8993(72)90653-1","article-title":"The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain","volume":"12","author":"McKean","year":"1972","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1651-2227.1987.tb10521.x","article-title":"Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria","volume":"76","author":"Lou","year":"1987","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0110","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/BF01805567","article-title":"Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases","volume":"5","author":"Pratt","year":"1982","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0115","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1523\/JNEUROSCI.14-05-03072.1994","article-title":"An animal model of early-treated PKU","volume":"5","author":"Diamond","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(95)70031-5","article-title":"Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria","volume":"127","author":"Pietz","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0125","first-page":"1261","article-title":"Cognition and tyrosine supplementation among school-aged children with phenylketonuria","volume":"146","author":"Mazzocco","year":"1992","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0130","first-page":"193","article-title":"Effect of tyrosine on attention deficit disorder with hyperactivity","volume":"49","author":"Eisenberg","year":"1988","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ymgme.2010.11.003_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0327(90)90017-3","article-title":"Tyrosine for depression: a double-blind trial","volume":"19","author":"Gelenberg","year":"1990","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0140","first-page":"441","article-title":"Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions?","volume":"21","author":"Tam","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1054-3589(08)61153-9","article-title":"Tryptophan hydroxylation in mammalian systems","volume":"6","author":"Lovenberg","year":"1968","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0150","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/S0021-9258(19)41399-9","article-title":"Tryptophan hydroxylase. Purification and some properties of the enzyme from rabbit hindbrain","volume":"250","author":"Tong","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0155","doi-asserted-by":"crossref","first-page":"e3301","DOI":"10.1371\/journal.pone.0003301","article-title":"Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants","volume":"3","author":"Savelieva","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2010.11.003_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.b.30168","article-title":"Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2)","volume":"135","author":"Coon","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgme.2010.11.003_bb0165","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.mp.4001698","article-title":"Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD","volume":"10","author":"Sheehan","year":"2005","journal-title":"Mol. Psychiatry"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T11:08:22Z","timestamp":1636801702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1096719210003951"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.11.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}